Senior Director - Health Economics Outcomes Research
Regeneron
Peter Lim Quon, MPH is a Senior Director of Health Economics and Outcomes Research (HEOR) at Regeneron Pharmaceuticals, where he serves dual roles as an expert advisor on health economic analyses for reimbursement submissions and as a disease modeler supporting clinical trial design and portfolio management decisions.
Peter brings 20 years of experience in health economic modeling to drug development. Prior to Regeneron, he spent 15 years at Evidera as a Senior Research Scientist and Research Director, consulting major pharmaceutical and biotech companies on health economic analyses for new drug submissions to health technology assessment (HTA) agencies globally.
Peter holds an MPH in Health Economics and Policy from George Washington University and a BS in Computational Biology from Brown University. He has authored numerous publications on the cost-effectiveness of new drugs and diagnostics across diverse therapeutic areas.
His passion is in finding opportunities to integrate health economics into US drug pricing strategies, promoting fair pricing that reflects societal value while sustaining investment incentives for continued innovation.
Disclosure information not submitted.
Early Health Economic Modeling: Preparing for Market Access Challenges
Saturday, October 18, 2025
10:45 AM - 11:00 AM MDT